JNJ - Johnson & Johnson -  [ ]

Ticker Details
Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
IPO Date: January 2, 1990
Sector: Healthcare
Industry: Pharma
Market Cap: $589.19B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.70 | 0.65%
Avg Daily Range (30 D): $1.79 | 0.81%
Avg Daily Range (90 D): $1.56 | 0.76%
Institutional Daily Volume
Avg Daily Volume: 7.95M
Avg Daily Volume (30 D): 7.02M
Avg Daily Volume (90 D): 6.35M
Trade Size
Avg Trade Size (Sh.): 136
Avg Trade Size (Sh.) (30 D): 42
Avg Trade Size (Sh.) (90 D): 40
Institutional Trades
Total Institutional Trades: 160,307
Avg Institutional Trade: $8.42M
Avg Institutional Trade (30 D): $29.91M
Avg Institutional Trade (90 D): $29.61M
Avg Institutional Trade Volume: .08M
Avg Institutional Trades (Per Day): 28
Market Closing Trades
Avg Closing Trade: $122.03M
Avg Closing Trade (30 D): $338.53M
Avg Closing Trade (90 D): $336.85M
Avg Closing Volume: 936.28K
 
News
Feb 12, 2026 @ 7:55 PM
NIH Stops Johnson & Johnson's Blood Thinner Drug A...
Source: Vandana Singh
Feb 12, 2026 @ 1:00 PM
BairesDev Named Top Global B2B Service Provider by...
Source: Not Specified
Feb 12, 2026 @ 10:37 AM
3 Earnings Winners Holding Strong in a Range-Bound...
Source: Damian Nowiszewski
Feb 11, 2026 @ 9:00 AM
Hepatitis B Treatment Market Size is Projected to ...
Source: Sns Insider
Feb 9, 2026 @ 12:25 PM
Johnson & Johnson Reports 90% AFib Freedom In Earl...
Source: Vandana Singh
Financials
  TTM Q4 2025 FY 2025
Basic EPS $11.13 $2.12 $11.13
Diluted EPS $11.03 $2.09 $11.03
Revenue $94.19B $24.56B $94.19B
Gross Profit $63.94B $16.6B $63.94B
Net Income / Loss $26.8B $5.12B $26.8B
Operating Income / Loss $32.58B $4.97B $32.58B
Cost of Revenue $30.26B $7.97B $30.26B
Net Cash Flow $-4396M $1.48B $-4396M
PE Ratio 22.19    
Splits
Jun 13, 2001 2:1